fluorouracil, epirubicin, and cyclophosphamide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for fluorouracil, epirubicin, and cyclophosphamide, covering 2023-03-06 to 2023-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer [Phase 3]